Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Nuvalent deal delivers GSK’s first-ever lung cancer approval
Jideytro’s FDA approval comes just a week after GSK closed the Nuvalent acquisition and about two months ahead of the regulator's PDUFA date.
Angus Liu
Jul 22, 2026 3:15pm
Trump floats countdown to 200% tariff rate on imported generics
Jul 22, 2026 11:00am
Operating at the speed of science: The new medical affairs playbook
Brought to you by
ZS
Summit updates ivonescimab survival data ahead of PDUFA
Jul 22, 2026 10:58am
Access: A key driver of non-opioid pain management adoption
Brought to you by
Pacira BioSciences, Inc.
Arrowhead data set up Redemplo for hypertriglyceridemia nod
Jul 22, 2026 10:52am
